Sigachi Industries files for IPO worth Rs 60 crore
Chennai: Hyderabad based, Sigachi Industries, manufacturers of cellulose based excipients in India, has filed its DRHP to raise approximately 60 crores, as per market sources. The IPO is a fresh issuance of upto 28,41,500 equity shares of face value of Rs 10 each.The company is engaged in the manufacturing of microcrystalline cellulose ("MCC"), the polymer is widely used for finished dosages...
Login or Register to read the full article
Chennai: Hyderabad based, Sigachi Industries, manufacturers of cellulose based excipients in India, has filed its DRHP to raise approximately 60 crores, as per market sources. The IPO is a fresh issuance of upto 28,41,500 equity shares of face value of Rs 10 each.
The company is engaged in the manufacturing of microcrystalline cellulose ("MCC"), the polymer is widely used for finished dosages in the pharmaceutical industry. The inert non-reactive, free flowing and versatile nature of MCC has varied applications in the pharmaceutical, food, nutraceuticals and the cosmetic industries.
Presently, the company manufactures 50 different grades of MCC at its manufacturing units, situated at Hyderabad and Gujarat under the brand named HiCel and AceCel.
The net proceeds of the issue are to be used for the expansion of production facilities of MCC at Dahej and Jhagadia in Gujarat between FY21 and FY22 as well as general corporate purposes. The proposed expansion will add 3600 MTPA capacity to the Dahej and Jhagadia facility, augmenting its capacity to 7890 MTPA and 5760 MTPA respectively.
Saffron Capital Advisors has been appointed as the BRLM to the Issue. The Equity Shares offered through the DRHP are proposed to be listed on the BSE and the NSE.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd